Forty-five states seek approval of generic price-fixing settlements with Ascend, Mayne and Citron
A 45-state coalition asked the court to approve settlements with three more generic manufacturers in the long-running price-fixing litigation. The monetary terms total $1.05 million; the larger cases against Teva, Sandoz and others continue.
A coalition of 45 states and territories announced on October 8, 2026, that it was seeking court approval of settlements with generic drug manufacturers Ascend Laboratories, Mayne Pharma and Citron Pharma. Massachusetts, Michigan and Tennessee were among the attorneys general announcing the deals.
The states allege the companies took part in a widespread, long-running conspiracy to inflate and manipulate generic drug prices, reduce competition and restrain trade. Consumers who bought generic prescription drugs in the United States between May 2009 and December 2019 may be eligible for compensation through the settlement administrator.
The amounts are small. Ascend agreed to pay $400,000 and Mayne $650,000. Citron, which has ceased operating, agreed to non-monetary terms only. All three agreed to injunctive provisions, including internal reforms and antitrust compliance measures. The announcements did not describe any admission of liability.
The settlements belong to a series of multistate antitrust actions filed since 2016. The second complaint, filed in 2019, names Teva and 21 other manufacturers plus 16 executives. A third complaint covering 80 drugs and 26 corporate defendants is to be tried first. A fourth, filed earlier in 2026, targets Novartis and Sandoz entities over Sandoz's alleged conduct and alleged fraudulent asset transfers. Sandoz separately sought approval of a roughly $469 million resolution with the states in early October.
The Ascend, Mayne and Citron deals remove three minor defendants. The substantive exposure in the litigation remains with the large manufacturers still contesting the claims.
Sources
- mass.gov · mass.gov/news/ag-campbell-seeks-court-approval-for-settlements-with-generic-drug-manufactu…
- michigan.gov · michigan.gov/ag/news/press-releases/2026/10/14/ag-nessel-seeks-settlements-with-drug-manuf…
- tn.gov · tn.gov/attorneygeneral/news/2026/10/13/pr26-46.html
Cite this report
The Precedent. "Forty-five states seek approval of generic price-fixing settlements with Ascend, Mayne and Citron." October 12, 2026. https://theprecedent.org/article/forty-five-states-seek-approval-of-generic-price-fixing-settlements-with-ascend
